| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024636708 |
| P356 | DOI | 10.1038/306584A0 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/306584a0 |
| P8608 | Fatcat ID | release_5o3svv43cfbwrbsxc7t54idfnu |
| P698 | PubMed publication ID | 6358901 |
| P50 | author | Julia Polak | Q6306664 |
| P2093 | author name string | Rossor MN | |
| Bloom SR | |||
| Ghatei MA | |||
| Crow TJ | |||
| Roberts GW | |||
| Adrian TE | |||
| Allen JM | |||
| Tatemoto K | |||
| P2860 | cites work | Neuropeptide Y: complete amino acid sequence of the brain peptide | Q34056649 |
| Neuropeptide Y Distribution in the Rat Brain | Q34247574 | ||
| Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide | Q42446741 | ||
| Neuropeptide coexistence in human cortical neurones. | Q48931335 | ||
| Bovine pancreatic polypeptide-like immunoreactivity in brain and peripheral nervous system: coexistence with catecholaminergic nerves. | Q48950457 | ||
| Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. | Q48955294 | ||
| Distribution of cholecystokinin-like peptides in the human-brain. | Q48959686 | ||
| Coexistence of somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivity in some forebrain neurons | Q49014823 | ||
| Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. | Q49119328 | ||
| Simultaneous localization of multiple tissue antigens using the peroxidase-labeled antibody method: a study on pituitary glands of the rat. | Q49149346 | ||
| Vascular effects of the peptides PYY and PHI: comparison with APP and VIP. | Q54512192 | ||
| The regional distribution of somatostatin, substance P and neurotensin in human brain | Q63608763 | ||
| Immunoreactive pancreatic polypeptide (PP) occurs in the central and peripheral nervous system: Preliminary immunocytochemical observations | Q66940252 | ||
| Coexistence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamines in some peripheral and central neurons | Q72628232 | ||
| An immunohistochemical study of neuronal populations containing neuropeptides or gamma-aminobutyrate within the superficial layers of the rat dorsal horn | Q72650621 | ||
| Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens | Q72690567 | ||
| Regional Distribution of Cholecystokinin-Like Immunoreactivity in the Human Brain* | Q72898956 | ||
| P433 | issue | 5943 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 584-586 | |
| P577 | publication date | 1983-12-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Neuropeptide Y distribution in human brain | |
| P478 | volume | 306 |
| Q50507629 | 5-HT(3A) receptor-bearing white matter interstitial GABAergic interneurons are functionally integrated into cortical and subcortical networks. |
| Q47811750 | A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder |
| Q48901958 | A comparison of the binding of [3H]proprionyl-neuropeptide Y to rat and human frontal cortical membranes. |
| Q24649537 | A role for brain stress systems in addiction |
| Q64949253 | Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis. |
| Q48863458 | Activation of alpha 1-adrenoceptors to lower cerebrocortical neuropeptide Y (NPY)-like immunoreactivity in rats receiving pargyline treatment. |
| Q43263351 | Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells |
| Q35073089 | Alcoholism: allostasis and beyond |
| Q44332829 | Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor |
| Q48973469 | Anti-nociceptive effect of neuropeptide Y in periaqueductal grey in rats with inflammation. |
| Q45946180 | Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence. |
| Q50784406 | Behavioural profile of a new mouse model for NPY deficiency. |
| Q39565590 | Broad spectrum antibiotic activity of the skin-PYY. |
| Q40829000 | Calcitonin gene-related peptide and neuropeptide Y in the raccoon cuneate nucleus |
| Q38247989 | Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers |
| Q74072617 | Cardiovascular actions of neuropeptide Y and social stress |
| Q41277218 | Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models |
| Q33921012 | Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls |
| Q41126100 | Changes in neuropeptide Y after experimental traumatic brain injury in the rat. |
| Q52143136 | Changes in the expression of neuropeptide Y (NPY) during maturation of human sympathetic ganglionic neurons: correlations with tyrosine hydroxylase immunoreactivity. |
| Q77512850 | Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor? |
| Q42502362 | Characterization and distribution of neuropeptide Y in the brain of a caecilian amphibian. |
| Q46498631 | Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart |
| Q42500050 | Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum |
| Q41726840 | Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line |
| Q35872833 | Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226. |
| Q48680116 | Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. |
| Q34631726 | Circuits and systems in stress. I. Preclinical studies |
| Q24336819 | Cloned human neuropeptide Y receptor couples to two different second messenger systems |
| Q28611135 | Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine |
| Q46886091 | Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus |
| Q48397809 | Colocalization of neuropeptide Y (NPY)-like and FMRFamide-like immunoreactivities in the brain of the Atlantic salmon (Salmo salar). |
| Q48436589 | Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. |
| Q36763736 | Comparative distribution of central neuropeptide Y (NPY) in the prairie (Microtus ochrogaster) and meadow (M. pennsylvanicus) vole |
| Q74567151 | Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions |
| Q48403276 | Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. |
| Q34470931 | Contrasting Effects of the Neuropeptides Substance P, Somatostatin, and Neuropeptide Y on the Methamphetamine-Induced Production of Striatal Nitric Oxide in Mice |
| Q48492958 | Cysteamine selectively enhances neuropeptide Y2 receptor binding activity |
| Q48461342 | Cytology and distribution in normal human cerebral cortex of neurons immunoreactive with antisera against neuropeptide Y. |
| Q49151018 | Decreased gastric acid output following neuropeptide Y administration into the lateral cerebral ventricle of conscious rats. |
| Q34337137 | Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice |
| Q48108438 | Development of immunoreactivity to neuropeptide Y in the brain of brown trout (Salmo trutta fario). |
| Q48143015 | Developmental study of neuropeptide Y-like immunoreactivity in the neurohypophysis and intermediate lobe of the rhesus monkey (Macaca mulatta). |
| Q37914972 | Diabetic neuropathy and heart failure: role of neuropeptides |
| Q69589165 | Differential colocalization of neuropeptide Y- and methionine-enkephalin-Arg6-Gly7-Leu8-like immunoreactivity in catecholaminergic neurons in the rat brain stem |
| Q87146810 | Distribution and characterization of neuropeptide Y-like immunoreactivity in the brain and pituitary of the goldfish |
| Q43947341 | Distribution and synaptic connectivity of neuropeptide Y-immunoreactive amacrine cells in the rat retina |
| Q48871166 | Distribution of catecholamine-synthesizing enzymes and some neuropeptides in the median eminence-arcuate nucleus complex (MEARC) of the immature female pig. |
| Q48333061 | Distribution of neurons and axons immunoreactive with antisera against neuropeptide Y in the normal human hippocampus |
| Q47316875 | Distribution of neuropeptide Y (NPY) in the cerebral cortex of the lizards Psammodromus algirus and podarcis hispanica: co-localization of NPY, somatostatin, and GABA. |
| Q42527573 | Distribution of neuropeptide Y immunoreactivity in the basal forebrain and upper brainstem of the squirrel monkey (Saimiri sciureus). |
| Q48310297 | Distribution of neuropeptide Y immunoreactivity in the central and peripheral nervous systems of amphioxus (Branchiostoma lanceolatum Pallas). |
| Q68086205 | Distribution of neuropeptide Y in the prosencephalon of man and cotton-head tamarin (Saguinus oedipus): colocalization with somatostatin in neurons of striatum and amygdala |
| Q80863145 | Distribution of neuropeptide Y-immunoreactive neurons in the human brainstem, cerebellum, and cortex during development |
| Q42461879 | Distribution of neuropeptide Y-like immunoreactivity in the brain and hypophysis of the cloudy dogfish, Scyliorhinus torazame |
| Q42461060 | Distribution of neuropeptide Y-like immunoreactivity in the brain of the lizard Gallotia galloti. |
| Q43565002 | Does neuropeptide Y contribute to the anorectic action of amylin? |
| Q27021306 | Dorsomedial hypothalamic NPY and energy balance control |
| Q37296820 | Dorsomedial hypothalamic NPY modulation of adiposity and thermogenesis |
| Q48603587 | Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats. |
| Q96648671 | Echinoderms provide missing link in the evolution of PrRP/sNPF-type neuropeptide signalling |
| Q48908236 | Effect of food manipulation on the neuropeptide Y neuronal system in the diencephalon of ewes. |
| Q55230943 | Effects of Dietary Acute Tryptophan Depletion (ATD) on NPY Serum Levels in Healthy Adult Humans Whilst Controlling for Methionine Supply-A Pilot Study. |
| Q48736817 | Effects of neuropeptide Y on forskolin, alpha2- and beta-adrenoceptor-regulated cAMP levels in the rat brain slice |
| Q34967570 | Emotion processing, major depression, and functional genetic variation of neuropeptide Y. |
| Q48308660 | Endocrine actions of central neuropeptide Y in the ewe: activation of the hypothalamo-pituitary-adrenal axis by exogenous neuropeptide Y and role of endogenous neuropeptide Y in the secretion of luteinizing hormone during the oestrous cycle |
| Q36745498 | Estrogen-related receptor β deletion modulates whole-body energy balance via estrogen-related receptor γ and attenuates neuropeptide Y gene expression |
| Q48359519 | Evidence for regulated expression of neuropeptide Y gene by rat and human cultured astrocytes |
| Q48277446 | Exogenous neuropeptide Y blocks myoelectric activity in the upper gastrointestinal tract of starved dogs. Brain neuropeptide Y converts a fasting pattern of myoelectric activity to a fed pattern |
| Q42466205 | Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. |
| Q62031248 | Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway |
| Q48278426 | Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture |
| Q47184218 | Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist |
| Q43564993 | Food intake inhibition and reduction in body weight gain in rats treated with GI264879A, a non-selective NPY-Y1 receptor antagonist |
| Q68294159 | Genetic mapping of the lurcher locus on mouse chromosome 6 using an intersubspecific backcross |
| Q37275653 | Genetic variation in human NPY expression affects stress response and emotion |
| Q33883621 | High-affinity neuropeptide Y receptor antagonists |
| Q37608792 | Humans and great apes share increased neocortical neuropeptide Y innervation compared to other haplorhine primates |
| Q34890607 | Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction |
| Q37039921 | Hypothalamic regulatory peptides and the regulation of food intake and energy balance: signals or noise? |
| Q62031381 | Immunocytochemical localization of neuropeptide Y (NPY) in the human hypothalamus |
| Q48424425 | Immunocytochemistry of human brain tissue with a polyclonal antiserum against neuropeptide Y. |
| Q42467377 | Immunohistochemical mapping of neuropeptide Y in the tree shrew brain. |
| Q38199487 | Individual differences in the neurobiology of social stress: implications for depression-cardiovascular disease comorbidity |
| Q68217451 | Inhibitory effect of neuropeptide Y (NPY) on the in vitro activity of dopamine-β-hydroxylase |
| Q51578866 | Inhibitory effect of propofol on sympathetic neurotransmission results in changes of plasma neuropeptide Y in rats. |
| Q48906091 | Innervation of the mink pineal gland with neuropeptide Y (NPY)-containing nerve fibers. An experimental immunohistochemical study. |
| Q33582362 | Interaction of neuropeptide Y genotype and childhood emotional maltreatment on brain activity during emotional processing |
| Q36909513 | Interaction of the neurotransmitter, neuropeptide Y, with phospholipid membranes: film balance and fluorescence microscopy studies |
| Q48933795 | Interleukin-1beta induces expression of neuropeptide Y in primary astrocyte cultures in a cytokine-specific manner: induction in human but not rat astrocytes. |
| Q73150075 | Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats |
| Q90669713 | Isolation and characterization of glycosylated neuropeptides |
| Q43900083 | Isolation and sequence of rat peptide YY and neuropeptide Y |
| Q37413160 | Isolation of pyroGlu-Gly-Arg-Phe-NH2 (Antho-RFamide), a neuropeptide from sea anemones |
| Q40698585 | Langerhans cell expression of neuropeptide Y and peptide YY. |
| Q36621739 | Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours |
| Q58049007 | Localization and characterization of neuropeptide Y-like peptides in the brain and islet organ of the anglerfish (Lophius americanus) |
| Q48407047 | Localization of NPY-immunoreactivity in the cat's visual cortex. |
| Q48692357 | Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum. |
| Q48677878 | Localization of neuropeptide Y-immunoreactive cells and fibres in the brain of the Japanese quail. |
| Q46976045 | Location of neuronal tangles in somatostatin neurones in Alzheimer's disease |
| Q42458265 | Mapping of neurons in the central nervous system of the guinea pig by use of antisera specific to the molluscan neuropeptide FMRFamide |
| Q33395501 | Mapping of the transcription start site (TSS) and identification of SNPs in the bovine neuropeptide Y (NPY) gene |
| Q33575295 | Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum |
| Q48466795 | Molecular characterization of neuropeptide Y (NPY) receptors (Y1, Y4 and Y6) and investigation of the tissue expression of their ligands (NPY, PYY and PP) in chickens. |
| Q38748846 | Molecular imaging probes derived from natural peptides. |
| Q52027171 | Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics. |
| Q48857283 | Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons. |
| Q48358909 | NPY and food intake: discrepancies in the model |
| Q38665001 | NPY binds with heme to form a NPY-heme complex: enhancing peroxidase activity in free heme and promoting NPY nitration and inactivation. |
| Q35130522 | NPY receptors as potential targets for anti-obesity drug development |
| Q42275340 | Neural sites of the human colon colocalize nitric oxide synthase-related NADPH diaphorase activity and neuropeptide Y |
| Q40802042 | Neuroendocrine regulation of thyrotropin-releasing hormone (TRH) in the tuberoinfundibular system |
| Q39343212 | Neuronal cholecystokinin: one or multiple transmitters? |
| Q98464641 | Neuronal diversity of the amygdala and the bed nucleus of the stria terminalis |
| Q48529638 | Neuropeptide Y (NPY) and C-flanking peptide of NPY in the pineal gland of normal and ganglionectomized sheep. |
| Q46360795 | Neuropeptide Y (NPY) inhibits spontaneous contraction of the mouse atrium by possible activation of the NPY1 receptor. |
| Q35540769 | Neuropeptide Y (NPY) innervation of the ovine pineal gland |
| Q36942971 | Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses |
| Q47590674 | Neuropeptide Y Impairs Retrieval of Extinguished Fear and Modulates Excitability of Neurons in the Infralimbic Prefrontal Cortex. |
| Q37675740 | Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats |
| Q40625857 | Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? |
| Q44410493 | Neuropeptide Y and lipid increase apolipoprotein AIV gene expression in rat hypothalamus |
| Q52071642 | Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively |
| Q46944577 | Neuropeptide Y and peptide YY immunoreactivities in the pancreas of various vertebrates |
| Q27030562 | Neuropeptide Y and posttraumatic stress disorder |
| Q58587344 | Neuropeptide Y and representation of salience in human nucleus accumbens |
| Q48651937 | Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats |
| Q41735768 | Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells |
| Q46454485 | Neuropeptide Y expression, localization and cellular transducing effects in HUVEC. |
| Q73372674 | Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: role of receptor subtype and nitric oxide |
| Q43810107 | Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man. |
| Q48953662 | Neuropeptide Y inhibits estrous behavior and stimulates feeding via separate receptors in Syrian hamsters. |
| Q40815722 | Neuropeptide Y inhibits the protein kinase C-stimulated Cl(-) secretion in the human colonic cell line HT29cl.19A cell line via multiple sites |
| Q37104106 | Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine |
| Q48377078 | Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain |
| Q40345222 | Neuropeptide Y input to the rat basolateral amygdala complex and modulation by conditioned fear |
| Q35232765 | Neuropeptide Y interaction with the adrenergic transmission line: a study of its effect on alpha-2 adrenergic receptors |
| Q67831377 | Neuropeptide Y levels in central and peripheral cerebrospinal fluid in patients with intracranial disorders |
| Q42951048 | Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease |
| Q37405891 | Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial |
| Q48589989 | Neuropeptide Y receptor in the rat brain. |
| Q37899561 | Neuropeptide Y receptors: autoradiographic distribution in the brain and structure-activity relationships |
| Q48087778 | Neuropeptide Y stimulates inositol phospholipid hydrolysis in rat brain miniprisms |
| Q54359182 | Neuropeptide Y, peptide YY, and sympathetic control of rectal tone and anal canal pressure in the cat. |
| Q55486626 | Neuropeptide Y, somatostatin, and cholecystokinin neurone preservation in anaplastic astrocytomas. |
| Q41733128 | Neuropeptide Y-induced feeding and its control. |
| Q74515922 | Neuropeptide Y-like immunoreactivity in lumbar cerebrospinal fluid of patients after severe head trauma |
| Q37898251 | Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses |
| Q30453815 | Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y. |
| Q26866326 | Neuropeptide regulation of signaling and behavior in the BNST. |
| Q48427327 | Neuropeptide tyrosine-like immunoreactive system in the brain, olfactory organ and retina of the zebrafish, Danio rerio, during development. |
| Q41932986 | Neuropeptide y receptor in bovine hippocampus is a Y2 receptor |
| Q52095258 | Neuropeptide-Y both improves and impairs delayed matching-to-sample performance in rats |
| Q37948072 | Neuropeptides and Alzheimer's disease |
| Q40940927 | Neuropeptides in neuroblastomas and ganglioneuromas. |
| Q48587993 | Neuropeptides in neurological tumours. |
| Q45298042 | Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study |
| Q47967640 | Neuropeptides in the lungfish brain: phylogenetic implication. |
| Q35048780 | Neuropeptides, food intake and body weight regulation: a hypothalamic focus |
| Q48284780 | Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type |
| Q48354916 | Neurotransmitter specificity of cells and fibers in the medial preoptic nucleus: an immunohistochemical study in the rat. |
| Q50542913 | No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population. |
| Q44130740 | Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels |
| Q30372686 | Npy deletion in an alcohol non-preferring rat model elicits differential effects on alcohol consumption and body weight. |
| Q44334670 | Orally administered rubiscolin-6, a δ opioid peptide derived from Rubisco, stimulates food intake via leptomeningeal lipocallin-type prostaglandin D synthase in mice |
| Q73816027 | Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma |
| Q48631133 | Organization of human hypothalamus in fetal development. |
| Q39127073 | Pathophysiology of Migraine: A Disorder of Sensory Processing |
| Q28217268 | Peptide YY: a key mediator of orexigenic behavior |
| Q72746892 | Peptide-containing nerves in human urinary bladder |
| Q46960107 | Phylogenetic and ontogenetic study of neuropeptide Y-containing nerves in the liver |
| Q58828840 | Possible relationship between neuropeptide Y (NPY) and major depression – evidence from human and animal studies |
| Q52485812 | Postnatal development of neuropeptide Y-like immunoreactivity in area 17 of normal and visually deprived rhesus monkeys. |
| Q41332355 | Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice |
| Q52069325 | Quantitative autoradiographic localization of neuropeptide Y (NPY) binding sites in rat posterior pituitary lobe. |
| Q48657000 | Receptor-selective analogs demonstrate NPY/PYY receptor heterogeneity in rat brain |
| Q69330544 | Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis |
| Q90264679 | Reduced Sensory-Evoked Locus Coeruleus-Norepinephrine Neural Activity in Female Rats With a History of Dietary-Induced Binge Eating |
| Q44348985 | Reduced neuropeptide Y concentrations in suicide brain |
| Q24321285 | Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain |
| Q42492881 | Regional distribution of neuropeptide Y and its receptor in the porcine central nervous system. |
| Q28273349 | Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain |
| Q33869523 | Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices |
| Q34865829 | Resilience to the effects of social stress: evidence from clinical and preclinical studies on the role of coping strategies |
| Q39514501 | Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems. |
| Q36111731 | Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens |
| Q43841956 | Solubilization of the Neuropeptide Y Receptor from Rat Brain Membranes |
| Q67515457 | Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA) |
| Q84880515 | Stimulatory effects of neuropeptide Y on the growth of orange-spotted grouper (Epinephelus coioides) |
| Q36356595 | Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. |
| Q34610652 | Structure and expression of the rat neuropeptide Y gene |
| Q34138015 | Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic- |
| Q36680065 | Surgical cure of hypertension in a patient with brainstem capillary haemangioblastoma containing neuropeptide Y. |
| Q30394984 | Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders |
| Q34568502 | The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics. |
| Q73457887 | The distribution of neuropeptide Y and brain-derived neurotrophic factor immunoreactivity in hippocampal formation of the monkey and rat |
| Q48138641 | The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. |
| Q48620377 | The effects of corticotropin-releasing hormone on peptidergic neurons in the rat forebrain |
| Q64298261 | The first identification of nesfatin-1-expressing neurons in the human bed nucleus of the stria terminalis |
| Q34130568 | The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. |
| Q26786672 | The role of Neuropeptide Y in fear conditioning and extinction |
| Q91911034 | The role of epigenetics in hypothalamic energy balance control: implications for obesity |
| Q37723803 | The role of neuropeptides in cardiovascular regulation |
| Q72806533 | The sympathetic and parasympathetic nature of neuropeptide Y-immunoreactive nerve fibres in the major salivary glands of the rat |
| Q28111988 | Tobacco addiction and the dysregulation of brain stress systems |
| Q26853074 | Toward an integration of cognitive and genetic models of risk for depression |
| Q48703416 | Tyrosine hydroxylase- and neuropeptide Y-immunoreactive nerve fibers in the pineal complex of untreated rats and rats following removal of the superior cervical ganglia |
| Q44917574 | Understanding and treating alcohol dependence |
| Q60920881 | Update on the pathophysiology of cluster headache: imaging and neuropeptide studies |
Search more.